[1]
Urszula Gadomska, “EXPANDING THE THERAPEUTIC LANDSCAPE OF SMA:  SAFETY AND EFFICIENCY OF APITEGROMAB”, IJITSS, vol. 3, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5976.